Recent research has revealed a number of links between inflammation and coa
gulation. The protein C anticoagulant pathway appears to be the major pathw
ay involved in the cross-talk between inflammation and coagulation. Studies
indicate that inflammatory mediators can downregulate key components of th
e pathway through transcriptional control, proteolytic inactivation and oxi
dant damage. In turn, in vine and in vitro studies have revealed mechanisms
by which the components of the pathway map inhibit inflammatory responses.
These include inhibition of cytokine responses to endotoxin, inhibition of
leukocyte attachment to the activated endothelium and inhibition of thromb
in and factor Xa generation in the microcirculation where both enzymes can
lead to endothelial cell activation, further potentiating the inflammatory
response. The ability of the protein C system to modulate both inflammation
and coagulation may explain in part why specific defects in the pathway ap
pear to be associated with both arterial and venous thrombosis. (C) 2000 Ac
ademic Press.